


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.53%
-4.48%
-10.17%
-2.00%
+0.30%
LCTX
Lineage Cell Therape
$1.25

Login to see Lineage Cell Therape (LCTX) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
LCTX Price Performance
$1.56 (-19.87%)
$1.82 (-31.32%)
$1.74 (-28.16%)
$0.67 (+86.57%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
LCTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LCTX Street Sentiment is not attractive and have negative views on the near-term outlook
LCTX has Medium risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Nov 25, 2025
Reiterate
Buy
D. Boral Capital
Nov 25, 2025
Reiterate
Buy
HC Wainwright & Co.
CGTX
Cognition Therapeutics
1.14
-5.00%
OCGN
Ocugen
1.39
-4.79%
PROK
ProKidney Corp.
1.66
-2.92%
MESO
Mesoblast Limited
14.99
-0.60%
NBIX
Neurocrine Biosciences
158.42
-0.40%
What is LCTX current stock price?
What is LCTX current Stock IQ?
What is LCTX RSI signal right now?
What is LCTX analyst price target and upside potential?
What do analysts say about LCTX stock?
What is LCTX momentum trend right now?
What are LCTX stock strengths?
What is LCTX Risk Level?
Should I buy LCTX stock right now?
Is LCTX a Strong Buy right now?
What is LCTX market cap and volume?
What factors influence LCTX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
LCTX
Lineage Cell Therape
Current Price
$1.25
CGTX
Cognition Therapeutics
1.14
-5.00%
OCGN
Ocugen
1.39
-4.79%
PROK
ProKidney Corp.
1.66
-2.92%
MESO
Mesoblast Limited
14.99
-0.60%
NBIX
Neurocrine Biosciences
158.42
-0.40%

LCTX Price Performance
$1.56 (-19.87%)
$1.82 (-31.32%)
$1.74 (-28.16%)
$0.67 (+86.57%)
LCTX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
LCTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LCTX Street Sentiment is not attractive and have negative views on the near-term outlook
LCTX has Medium risk level

Overall Wall Street Rating
LCTX Stock IQ
Stock Insights
Not Enough Information
LCTX Trading Signals
LCTX opened with a gap down of 3.82% (prev close $1.31, open $1.26)
LCTX showing early bearish trend, price below MA20 (1.47) and MA20 below MA50 (1.58)
LCTX is trading 26.26% below analyst target price of $1.58, suggesting significant upside potential
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
LCTX Stock trends
LCTX Stock performance
LCTX Stock analysis
LCTX investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.